Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers

NCT02172222 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 10773
DRUG: Linagliptin

Sponsor

Boehringer Ingelheim